ArticleFrontiers in medicine2026
Clinical features and early warning factors of symptomatic pulmonary embolism after total joint arthroplasty: a retrospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Symptomatic pulmonary embolism (PE) is a severe and life-threatening complication following total joint arthroplasty (TJA). Despite advances in diagnosis, treatment, and prediction, postoperative PE still occurs. This study aimed to investigate the onset time window, initial clinical presentations, and preoperative comorbidity profiles of patients with symptomatic PE after TJA, thereby providing clinical evidence for early identification and perioperative management of post-TJA PE. Methods: In this retrospective study, patients who underwent TJA at our institution between January 2023 and December 2025 and were diagnosed with postoperative PE via computed tomography pulmonary angiography were assigned to the case group. Non-PE patients were randomly selected at a 1:2 ratio as controls. Data collected included baseline patient characteristics, surgical procedure, time from surgery to PE onset, chief complaints at onset, BMI, and preoperative comorbidities. Age-stratified analyses were conducted to compare symptom distributions. Multivariable logistic regression was then performed to evaluate the associations between physiological parameters, chief complaints, and PE at onset, and the diagnostic performance of identified warning factors was calculated. Results: A total of 5,120 patients who underwent TJA were evaluated. Symptomatic PE was diagnosed in 84 patients (1.64%), with a mean age of 67.4 ± 8.8 years. Among these, 73 underwent total knee arthroplasty (TKA) and 11 underwent total hip arthroplasty (THA). The mean time from surgery to PE onset was 51.8 ± 26.1 h, with 72 cases (85.7%) occurring within 72 h postoperatively. No significant differences in preoperative comorbidities were observed between the two groups ( Conclusion: Post-TJA PE predominantly occurs within 72 h postoperatively. Decreased SpO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.